Literature DB >> 25664843

A reappraisal of the association between Behçet's disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review.

Sinem Nihal Esatoglu1, Gulen Hatemi2, Ayse Salihoglu3, Ibrahim Hatemi4, Teoman Soysal3, Aykut Ferhat Celik4.   

Abstract

OBJECTIVES: A number of patients with Behçet's disease (BD) associated with myelodysplastic syndrome (MDS) with or without trisomy 8 have been reported. A high frequency of gastrointestinal (GI) involvement was reported in such patients. The aim of this systematic literature review was to delineate whether GI involvement is an inherent feature of BD associated with MDS, whether these patients do actually have BD rather than GI symptoms related to MDS, and whether the presence of trisomy 8 plays a role in the disease expression of BD associated with MDS.
METHODS: A systematic literature review was performed in PubMed using the keywords (Behçet's disease OR Behçet's syndrome) AND (myelodysplastic syndrome OR trisomy 8) until December 2013.
RESULTS: Data from 39 manuscripts that met the inclusion criteria, reporting on 52 patients were analysed. GI involvement was common in reports from both the Far East and non-Far East countries (75% vs. 50.0%, p=0.15). These patients had typical BD manifestations, except for 1 patient who had only oral ulcers and gastrointestinal involvement. The presence of trisomy 8 seems to be associated with an increased frequency of fever (79.5% vs. 33.3%, p=0.005).
CONCLUSIONS: GI involvement seems to be an inherent feature of BD associated with MDS regardless of geographic differences. Despite the increased frequency of GI involvement in these patients, MDS does not seem to modify the clinical expression of gastrointestinal involvement. Presence of trisomy 8 seems to modify the disease expression with an increased frequency of fever.

Entities:  

Mesh:

Year:  2015        PMID: 25664843

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  9 in total

1.  Indications for bone marrow examinations in rheumatology.

Authors:  Hava Üsküdar Teke; Döndü Üsküdar Cansu; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2019-04-30       Impact factor: 2.631

2.  Trisomy 8 Associated Clonal Cytopenia Featured With Acquired Auto-Inflammation and Its Response to JAK Inhibitors.

Authors:  Yakai Fu; Wanlong Wu; Zhiwei Chen; Liyang Gu; Xiaodong Wang; Shuang Ye
Journal:  Front Med (Lausanne)       Date:  2022-04-25

Review 3.  Update on the treatment of Behçet's syndrome.

Authors:  Sinem Nihal Esatoglu; Gulen Hatemi
Journal:  Intern Emerg Med       Date:  2019-01-25       Impact factor: 3.397

4.  Characteristics, Treatment, and Long-Term Outcome of Gastrointestinal Involvement in Behcet's Syndrome: A Strobe-Compliant Observational Study From a Dedicated Multidisciplinary Center.

Authors:  Ibrahim Hatemi; Sinem Nihal Esatoglu; Gulen Hatemi; Yusuf Erzin; Hasan Yazici; Aykut Ferhat Celik
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  High Incidence of Gastrointestinal Ulceration and Cytogenetic Aberration of Trisomy 8 as Typical Features of Behçet's Disease Associated with Myelodysplastic Syndrome: A Series of 16 Consecutive Chinese Patients from the Shanghai Behçet's Disease Database and Comparison with the Literature.

Authors:  Yan Shen; Hai-Fen Ma; Dan Luo; Jian-Fei Cai; Jun Zou; Jian-Long Guan
Journal:  Biomed Res Int       Date:  2018-04-24       Impact factor: 3.411

6.  Mutation of ten-eleven translocation-2 is associated with increased risk of autoimmune disease in patients with myelodysplastic syndrome.

Authors:  Yoon-Jeong Oh; Dong-Yeop Shin; Sang Mee Hwang; Sung-Min Kim; Kyongok Im; Hee Sue Park; Jung-Ah Kim; Yeong Wook Song; Ana Márquez; Javier Martín; Dong-Soon Lee; Jin Kyun Park
Journal:  Korean J Intern Med       Date:  2019-10-25       Impact factor: 2.884

7.  Successful allogeneic bone marrow transplantation after massive gastrointestinal bleeding in a patient with myelodysplastic syndrome associated with intestinal Behçet-like disease.

Authors:  Arata Ishii; Shokichi Tsukamoto; Tatsuzo Mishina; Shintaro Izumi; Yurie Nagai; Miki Yamazaki; Yutaro Hino; Kensuke Kayamori; Nagisa Oshima-Hasegawa; Tomoya Muto; Shio Mitsukawa; Yusuke Takeda; Naoya Mimura; Chikako Ohwada; Chiaki Nakaseko; Jun-Ichiro Ikeda; Emiko Sakaida
Journal:  Leuk Res Rep       Date:  2021-10-29

8.  Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet's disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants.

Authors:  Kenji Watanabe; Satoshi Tanida; Nagamu Inoue; Reiko Kunisaki; Kiyonori Kobayashi; Masakazu Nagahori; Katsuhiro Arai; Motoi Uchino; Kazutaka Koganei; Taku Kobayashi; Mitsuhiro Takeno; Fumiaki Ueno; Takayuki Matsumoto; Nobuhisa Mizuki; Yasuo Suzuki; Tadakazu Hisamatsu
Journal:  J Gastroenterol       Date:  2020-05-07       Impact factor: 7.527

Review 9.  Understanding Behçet's Disease in the Context of Innate Immunity Activation.

Authors:  Sandro F Perazzio; Luis E C Andrade; Alexandre W S de Souza
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.